The largest database of trusted experimental protocols

Distearoylphosphatidylcholine

Manufactured by Avanti Polar Lipids
Sourced in United States

Distearoylphosphatidylcholine is a synthetic lipid compound commonly used in laboratory research. It is a form of phosphatidylcholine, a class of phospholipids found in cell membranes. Distearoylphosphatidylcholine has two stearic acid chains attached to the phosphatidylcholine backbone.

Automatically generated - may contain errors

17 protocols using distearoylphosphatidylcholine

1

Microbubble-Mediated miR-4284 Inhibitor Delivery

Check if the same lab product or an alternative is used in the 5 most similar protocols
The method of obtaining microbubbles was according to the protocol of a previous study (16 (link)). It was performed by sonication of 0.4 mg/ml 1,2-distearoyl-3-trimethylammoniumpropane (Avanti Polar Lipids, Inc.) with 1 mg/ml polyethyleneglycol-2000 stearate (Avanti Polar Lipids, Inc.), 2 mg/ml distearoylphosphatidylcholine (Avanti Polar Lipids, Inc.) and perfluoropropane gas. miR-4284 inhibitor (5'-AUGGGGUAUGUGAGCCC-3') or non-targeting inhibitor-NC (5'-CAGUACUUUUGUGUAGUACAA-3') was incubated with the microbubbles for 30 min at 37˚C. According to the manufacturer's protocol, the mixtures were added to A549 and H460 cells and transfected with Lipofectamine 3000 (Invitrogen; Thermo Fisher Scientific, Inc.).
+ Open protocol
+ Expand
2

Biotinylated Microbubble Preparation for VEGFR2 Targeting

Check if the same lab product or an alternative is used in the 5 most similar protocols
Laboratory-made lipid-shelled biotinylated MBs were prepared. By sonicating decafluorobutane gas (F2 Chemicals, Lancashire, UK) with a lipid micellar mixture of polyethylene glycol stearate (Stepan Kessco, Elwood, IL, USA), distearoyl phosphatidylcholine (Avanti Polar Lipids, Alabaster, AL, USA) and biotin-PEG3400-distearoylphosphatidylethanolamine (biotin-PEG-DSPE, Laysan Bio, Arab, AL, USA) in saline, biotinylated MBs were fabricated. VEGFR2-targeted MBs were prepared by conjugating biotinylated anti-mouse VEGFR2 antibody (clone Avas 12a1, eBioscience, San Diego, CA, USA) to the bubbles using a streptavidin linker 30 (link)–32 (link).
+ Open protocol
+ Expand
3

Targeted Microbubble Preparation for Cellular Binding

Check if the same lab product or an alternative is used in the 5 most similar protocols
Perfluorocarbon-filled, microbubbles with a lipid shell were prepared by sonicating an aqueous suspension of distearoyl phosphatidylcholine (2mg/ml; Avanti Polar Lipids, Alabaster AL, USA) and polyoxyethylene-(40)-stearate (1mg/ml; Sigma) that was gas-saturated. For targeting of microbubbles to leukocytes (MBLc), distearoyl-phosphatidylserine (0.3mg/ml; Avanti Polar Lipids) was added to the suspension before sonication [8 (link)]. For targeting of P-Selectin (MBPSel) and CD4 (MBCD4), distearoyl-phosphatidylethanolamine-PEG(3400)-biotin (0.14mg/ml; Creative PEG Works) was added to the suspension. Anti-P-Selectin antibody (RB40.34) or anti-CD4 antibody (H129.19) were then conjugated to the microbubble shell using biotin-streptavidin linking as previously described [9 (link)]. Control microbubbles (MBIso) with a non-specific control antibody of the same isotype (R3-34) were also prepared. We have previously shown that these protocols result in microbubbles of similar mean sizes of 2.5 to 2.7μm [7 ].
+ Open protocol
+ Expand
4

Targeted Microbubble Preparation and Conjugation

Check if the same lab product or an alternative is used in the 5 most similar protocols
Microbubbles were prepared in-house using previously described methods (Klibanov et al. 1999 ; Klibanov et al. 2006 ). Briefly, biotinylated MBs were formed by sonicating decafluorobutane gas (F2 Chemicals, Lancashire, UK) with a lipid micellar mixture of distearoyl phosphatidylcholine (Avanti Polar Lipids, Alabaster, AL, USA), polyethylene glycol stearate (Stepan Kessco, Elwood, IL, USA) and biotin-PEG3400-distearoylphosphatidylethanolamine (PEG-DSPE, Shearwater Polymers, Huntsville, AL, USA) in normal saline. After MBs were counted using a Coulter Multisizer 3 (Beckman Coulter, Brea, CA, USA) streptavidin (Anaspec Inc, Fremont, CA, USA) was added as a linking molecule at a concentration of 3 µg/10 million microbubbles (Lindner et al. 2001 ).
MBs were divided into two groups for conjugation to two types of antibodies. The first group was conjugated to biotinylated anti-mouse vascular endothelial growth factor receptor 2 (VEGFR2) antibody (clone Avas 12a1, eBioscience, San Diego, CA, USA) (Lee et al. 2008 ; Pochon et al. 2010 ; Willmann et al. 2008c (link); Willmann et al. 2008a (link)) and the second group was conjugated to biotinylated isotype control antibody (clone R35–95, BD Pharmingen, San Diego, CA, USA). All MBs were conjugated within 48 hours before use. Prior to each experiment, MB concentration was measured using a Coulter Multisizer 3.
+ Open protocol
+ Expand
5

Valsartan Lipid Nanoparticle Formulation

Check if the same lab product or an alternative is used in the 5 most similar protocols
Valsartan was purchased from Tecoland Corporation, (Irvine, CA, USA). Soy phosphatidylcholine (SPC), distearoyl phosphatidylcholine (DSPC), hydrogenated Soy phosphatidylcholine (HSPC), dimyristoylphosphatidylcholine (DMPC), and dimyristoyl phosphatidylglycerol sodium (DMPG) were purchased from Avanti Polar Lipids (Alabaster, AL, USA); cholesterol was purchased from Sigma-Aldrich, (St. Louis, MO, USA). Capmul MCM was purchased from Abitech Corporation (Janesville, WI, USA). Labrafil M 2125 was purchased from Alfa Chemicals (Binfield, Berkshire, UK). Tween 80 was purchased from EMD (Billerica, Massachussetts, USA). Avicel PH102 was purchased from FMC BioPolymers (Philadelphia, PA USA). Cell culture media were purchased from ATC Collection (Manassas, VA, USA); Transwell® plates (6-well) were purchased from Corning Life Sciences (Tewksbury, MA, USA). Cannulated Sprague-Dawley (SD) rats were purchased from Harlan Laboratories (Indianapolis, IN, USA); blank rat plasma was obtained from Biomedical (Winchester, VA, USA). Hard gelatin capsules (size 1) were purchased from Capsugel Inc., Morristown, NJ, USA, and all other reagents used are of analytical grade.
+ Open protocol
+ Expand
6

Phospholipid Characterization with ADIFAB

Check if the same lab product or an alternative is used in the 5 most similar protocols
The following phospholipids were purchased from Avanti Polar Lipids (Alabaster, Alabama): Dipalmitoyl-phosphatidylcholine (DPPC) and Distearoyl-phosphatidylcholine (DSPC). Trans-Resveratrol (>99% purity) was obtained from TCI of America, Phosphate-Buffered Saline (PBS), pH 7.4 was purchased from Sigma-Aldrich, St. Louis, Missouri. Phospholipase A2 (PLA2) from honey bees, and PLA1 from Thermomyces lanuginosus were purchased from Sigma-Aldrich. Acrylodan-labelled Intestinal Fatty Acid Binding Protein (ADIFAB) and ADIFAB2 were purchased from FFA Sciences, San Diego, California.
+ Open protocol
+ Expand
7

Microbubble-Mediated Delivery of miR-492 Inhibitor

Check if the same lab product or an alternative is used in the 5 most similar protocols
In the experiment, the microbubbles were obtained by ultrasonic treatment. The microbubbles were performed by sonication of 0.4 mg/ml 1,2-distearoyl-3-trimethylammoni-umpropane (Avanti Polar Lipids, Inc.) with 1 mg/ml polyethyleneglycol-2000 stearate (Avanti Polar Lipids, Inc.), 2 mg/ml distearoylphosphatidylcholine (Avanti Polar Lipids, Alabaster, Inc.) and perfluoropropane gas, the ultrasonic irradiation intensity was 0.5 W/cm2 and the irradiation time was 60 s. miR-492 inhibitor or inhibitor NC was incubated with the microbubbles for 30 min at 37 °C. The mixture was added to A549 and PC9 cells and transfected with Lipofectamine 3000 (Invitrogen; Thermo Fisher Scientific, Inc.), then ultrasound irradiation was applied with an irradiation intensity of 0.5 W/cm2.
+ Open protocol
+ Expand
8

Preparation of Lipid-Shelled Microbubbles

Check if the same lab product or an alternative is used in the 5 most similar protocols
Following Mott et al. [26 (link)], lipid-shelled MB-PS were prepared by performing a sonication of a decafluorobutane gas-saturated aqueous suspension of 2 mg/mL distearoylphosphatidylcholine, 0.3 mg/mL distearoyl phosphatidylserine (Avanti Polar Lipids, Alabaster, AL, USA), and 1 mg/mL polyoxyethylene-40-stearate (Sigma-Aldrich, St. Louis, MO, USA). The fluorescent lipid-shelled MB-PS were prepared by adding 0.2 mg/mL tetramethylindocarbocyanine perchlorate (Sigma-Aldrich, St. Louis, MO, USA) or 0.2 mg/mL dioctadecyloxacarbocyanine perchlorate (Invitrogen, Waltham, MA, USA) to the gas-saturated aqueous suspension described above.
+ Open protocol
+ Expand
9

Cisplatin-Loaded Lipid Nanoparticles for Cancer Therapy

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cisplatin (DDP) was purchased from Shandong Boyuan Pharmaceutical Co., Ltd (Ji’nan, China). Distearoylphosphatidylcholine (DSPC), distearoyl-N-(monomethoxy poly(ethylene glycol)succinyl)phosphatidylethanolamine (DSPE-PEG), distearoyl-N-(3-carboxy-propionoylpoly (ethyleneglycol) succinl) phosphatidylethanolamine (DSPE-PEG-COOH), and 1,2-dioleoyl-3-trimethyl-ammoniumpropane (DOTAP) were purchased from Avanti Polar Lipids, China. MiR-1284 was purchased from GenePharma Co., Ltd. (Shanghai, China). Dimehyl-2-thiazolyl)-2,5-diphenyl-2H-tetrazolium bromide (MTT). All other chemicals were of analytical grade.
+ Open protocol
+ Expand
10

Microbubble-Mediated Delivery of miR-492 Inhibitor

Check if the same lab product or an alternative is used in the 5 most similar protocols
In the experiment, the microbubbles were obtained by ultrasonic treatment. The microbubbles were performed by sonication of 0.4 mg/ml 1,2-distearoyl-3-trimethylammoni-umpropane (Avanti Polar Lipids, Inc.) with 1 mg/ml polyethyleneglycol-2000 stearate (Avanti Polar Lipids, Inc.), 2 mg/ml distearoylphosphatidylcholine (Avanti Polar Lipids, Alabaster, Inc.) and perfluoropropane gas, the ultrasonic irradiation intensity was 0.5 W/cm2 and the irradiation time was 60 s. miR-492 inhibitor or inhibitor NC was incubated with the microbubbles for 30 min at 37 °C. The mixture was added to A549 and PC9 cells and transfected with Lipofectamine 3000 (Invitrogen; Thermo Fisher Scientific, Inc.), then ultrasound irradiation was applied with an irradiation intensity of 0.5 W/cm2.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!